Creatine supplementation does not promote tumor growth or enhance tumor aggressiveness in Walker-256 tumor-bearing rats

• Published in: Nutrition (Burbank, Los Angeles County, Calif.) Vol. 79-80; p. 110958
• Main Authors: Cella, Paola Sanches, Marinello, Poliana C., Padilha, Camila S., Testa, Mayra T., Guirro, Philippe B., Cecchini, Rubens, Duarte, José A., Guarnier, Flávia A., Deminice, Rafael
• Format: Journal Article
• Language: English
• Published: Kidlington Elsevier Inc 01.11.2020; Elsevier Limited
• Subjects: Animals; Antibodies; Apoptosis; Body weight; Cancer; Carcinoma; Cell differentiation; Cell growth; Cell proliferation; Creatine; Creatine supplementation; Differentiation (biology); Drinking water; histopathology; males; neoplasms; nutrition; Parameters; Software; Supplements; Tumor aggressiveness; Tumor cells; Tumors; Walker-256; Tumor aggressiveness; Creatine supplementation; Carcinoma; Walker-256
• ISSN: 0899-9007; 1873-1244; 1873-1244
• DOI: 10.1016/j.nut.2020.110958

•Creatine supplementation does not enhance tumor growth.•Creatine supplementation does not change tumor morphology and aggressiveness.•Creatine supplementation does not change tumor cell proliferation or apoptosis. This study aimed to analyze the effect of creatine (Cr) supplementation on tumor microenvironment, evaluating the parameters of tumor aggressiveness. Sixteen male Wistar rats were randomly assigned to 2 groups (n = 8/group): Tumor-bearing (T) and tumor-bearing supplemented with Cr (TCr). Cr supplementation was provided in drinking water for a total of 21 d. After 11 d of Cr supplementation (TCr group) or water (T group), Walker-256 tumor cells were inoculated subcutaneously in the right flank of all rats, which kept receiving Cr supplementation (TCr group) or water (T group) for 10 more days. The total period of the experiment was 21 d. Tumor weight corresponded with approximately 3.5% ± 0.9% of animal body weight in the T group. Cr supplementation did not accelerate tumor growth or increase tumor size. The histopathological analysis demonstrated the presence of nuclear pleomorphisms and atypical nuclei, with the presence of low-differentiated tumor cells, in both groups. Cr supplementation did not alter apoptosis and cell proliferation markers, nor tumor capsule thickness and viable tumor area. Cr supplementation in Walker-256 tumor-bearing rats did not induce significant changes in tumor development, and did not interfere with the parameters of tumor aggressiveness, such as the level of cell differentiation and proliferation.